Theratechnologies Inc. (NASDAQ: THTX)
$1.58
+0.0402 ( +2.61% ) 127.1K
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
Market Data
Open
$1.58
Previous close
$1.54
Volume
127.1K
Market cap
$72.65M
Day range
$1.53 - $1.63
52 week range
$0.88 - $3.44
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 2 | Oct 24, 2023 |
6-k | Quarterly Reports | 2 | Oct 16, 2023 |
6-k | Quarterly Reports | 4 | Sep 26, 2023 |
6-k | Quarterly Reports | 6 | Sep 26, 2023 |
6-k | Quarterly Reports | 2 | Sep 25, 2023 |
6-k | Quarterly Reports | 2 | Sep 25, 2023 |
6-k | Quarterly Reports | 3 | Jul 31, 2023 |
6-k | Quarterly Reports | 3 | Jul 28, 2023 |
6-k | Quarterly Reports | 2 | Jul 27, 2023 |
6-k | Quarterly Reports | 3 | Jul 20, 2023 |